Trial Profile
A phase IIa trial of remogliflozin etabonate in obese patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Remogliflozin etabonate (Primary)
- Indications Obesity
- Focus Proof of concept; Therapeutic Use
- Sponsors BHV Pharma
- 08 Mar 2016 New trial record